Shenyang Northern Hospital
Clinical trials sponsored by Shenyang Northern Hospital, explained in plain language.
-
Heart rhythm breakthrough? new ablation combo targets stubborn AFib
Disease control Not yet recruitingThis study compares two heart procedures for people with persistent atrial fibrillation (AFib) lasting 6 months to 3 years. One group gets standard pulmonary vein isolation (PVI) ablation, while the other gets PVI plus an extra ablation on the Bachmann bundle. The goal is to see …
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heart study tests safer blood thinner for High-Risk patients
Disease control Not yet recruitingThis study compares two blood thinners, bivalirudin and heparin, used during a heart procedure called PCI in people with acute coronary syndrome who are at high risk of bleeding. About 5,270 participants will be randomly assigned to receive one of the two drugs. The goal is to se…
Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Shorter blood thinner course after stents may cut bleeding risk
Disease control Not yet recruitingThis study tests whether heart attack patients with high bleeding risk can safely take blood thinners for only one month after a special drug-coated stent, instead of the usual 12 months. About 468 participants will be randomly assigned to the shorter or standard therapy. The goa…
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Heart attack survivors may get Anti-Inflammatory boost from diabetes drug
Disease control Not yet recruitingThis study tests whether dapagliflozin, a drug typically used for diabetes, can lower inflammation in the heart arteries of people who recently had a heart attack but do not have diabetes or heart failure. About 110 participants will receive either the drug plus standard care or …
Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New quality check aims to reduce bleeding risks in heart patients
Knowledge-focused Not yet recruitingThis study looks at how well hospitals follow guidelines for blood thinner use after heart stent placement. It will enroll 3,500 patients with acute coronary syndrome who are at high risk for bleeding. Researchers will track their treatment and outcomes for 12 months to see if a …
Sponsor: Shenyang Northern Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC